PLX-IBD
/ Pluri
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
June 19, 2014
Pluristem granted patent in Russia for treatment of inflammatory bowel disease using placenta-derived cells
(GlobeNewswire)
- "Pluristem Therapeutics...announced that Russia's Federal Service for Intellectual Property has granted to Pluristem Patent No. 2515156 titled, 'Methods of Treating Inflammatory Colon Diseases'. The patent covers methods for treating ulcerative colitis or Crohn's disease using placenta-derived cells."
Patent • Inflammatory Bowel Disease
1 to 1
Of
1
Go to page
1